| First Author | Xing L | Year | 2025 |
| Journal | iScience | Volume | 28 |
| Issue | 11 | Pages | 113684 |
| PubMed ID | 41146712 | Mgi Jnum | J:374366 |
| Mgi Id | MGI:8258506 | Doi | 10.1016/j.isci.2025.113684 |
| Citation | Xing L, et al. (2025) A luminescence-based biosensor to measure endogenous UBE3A activity. iScience 28(11):113684 |
| abstractText | Loss- and gain-of-function (LOF and GOF) mutations in the E3 ubiquitin ligase UBE3A cause distinct neurodevelopmental disorders. The AZUL domain of UBE3A binds with low nanomolar affinity to a 45 amino acid (aa) region of PSMD4. We fused this 45-aa sequence to Firefly luciferase to generate a luminescence-based biosensor, Firefly-45aa, that acts as an artificial UBE3A substrate and exhibits exceptional sensitivity in measuring UBE3A activity. Testing UBE3A variants using Firefly-45aa in HEK293T cells revealed distinct biosensor activity profiles, enabling the classification of LOF and GOF mutations based on maximum activity, inhibitory concentration-50, and activity per unit of protein. Some strong LOF mutations had dominant negative activity. In addition, Firefly-45aa can be used to quantify endogenous UBE3A activity in primary cells from Angelman syndrome and GOF mouse models. This biosensor reveals a mutational spectrum of UBE3A enzyme activity and is a sensitive tool for functional characterization and therapeutic development in UBE3A-related disorders. |